Skip to main content
Signal8

Gentile Kimberly

SEC insider (Form 3/4/5 filer). CIK 0001704186. SVP, Clinical Operations at Biohaven Ltd. (BHVN). 8 reported Form 4/5 transactions since Sep 2024; latest on Sep 15, 2026. Located in NEW HAVEN, CT.

Companies Gentile Kimberly has filed insider reports for

  • Biohaven Ltd. (BHVN): Officer, SVP, Clinical Operations
Gentile Kimberly profile photo

Gentile Kimberly

CIK: 0001704186

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (25.0%)

Derivative conversions

Awards (A)4 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Biohaven Ltd. logo
BHVN

Biohaven Ltd.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

  • Biohaven Ltd. logo
    BHVN

    Biohaven Ltd.

    Sep 15, 2026
    Award

    Stock Options (Right to buy)

    Indirect
    1K shares-
  • Biohaven Ltd. logo
    BHVN

    Biohaven Ltd.

    Feb 27, 2026
    Award

    Stock Options (Right to buy)

    Direct
    175K shares-
  • Biohaven Ltd. logo
    BHVN

    Biohaven Ltd.

    Jan 5, 2026
    Exercise
    Direct
    3.8K shares-
  • Biohaven Ltd. logo
    BHVN

    Biohaven Ltd.

    Jan 5, 2026
    Tax Payment
    Direct
    2K shares at avg. $9.93$19K
  • Biohaven Ltd. logo
    BHVN

    Biohaven Ltd.

    Jan 5, 2025
    Exercise
    Direct
    3.8K shares-
  • Biohaven Ltd. logo
    BHVN

    Biohaven Ltd.

    Jan 5, 2025
    Tax Payment
    Direct
    2K shares at avg. $38.64$76K
  • Biohaven Ltd. logo
    BHVN

    Biohaven Ltd.

    Jan 5, 2025
    Award

    Stock Options (Right to buy)

    Direct
    91K shares-
  • Biohaven Ltd. logo
    BHVN

    Biohaven Ltd.

    Jan 5, 2025
    Award

    Restricted Share Unit Award

    Direct
    15K shares-

1-8 of 8